Highly sensitive LC-MRM workflow for quantitation of efflux transporters in rat peripheral blood mononuclear cells: leveraging ProteoExcelTP with MRM prediction capability

IF 3.6 3区 化学 Q2 CHEMISTRY, ANALYTICAL
Analyst Pub Date : 2025-01-27 DOI:10.1039/D4AN01514B
Tarang Jadav, Niraj Rajput and Pinaki Sengupta
{"title":"Highly sensitive LC-MRM workflow for quantitation of efflux transporters in rat peripheral blood mononuclear cells: leveraging ProteoExcelTP with MRM prediction capability","authors":"Tarang Jadav, Niraj Rajput and Pinaki Sengupta","doi":"10.1039/D4AN01514B","DOIUrl":null,"url":null,"abstract":"<p >Although combinational antiretroviral therapy has been proven highly effective, it suffers from drug–drug interactions, drug resistance and adverse reactions with long-term use. The introduction of novel drugs in antiretroviral therapy proposes newer treatment options. However, drug safety and their potential interactions after long-term therapy remain largely unexplored. In this study, the induction potential of bictegravir on efflux transporters at the protein level was assessed by quantifying the transporters using an LC-MS/MS-based method. A surrogate peptide approach was used for the simultaneous determination of P-gp, BCRP and MRP1 transporter proteins in rat peripheral blood mononuclear cells. The previously developed Excel-based ProteoExcel<small><sup>TP</sup></small> tool was utilized for selecting surrogate peptides corresponding to the target transporters. Moreover, ProteoExcel<small><sup>TP</sup></small> was integrated with a novel MRM prediction capability for predicting MRM transitions of selected surrogate peptides. The surrogate peptides LLSGQALK (415.2 → 716.4), SSLLDVLAAR (522.8 → 288.1) and EDLDLVLK (472.7 → 685.3) were selected for P-gp, BCRP and MRP1 transporter proteins, respectively. The peptides LLSGQALK, SSLLDVLAAR and EDLDLVLK were eluted at 5.4, 7.0 and 4.1 min, respectively. The findings of the study revealed that bictegravir could significantly induce BCRP transporter after one week of its administration to Sprague-Dawley rats. This finding can be utilized in the future to prevent transporter-mediated drug–drug interactions involving bictegravir. Moreover, the addition of MRM prediction feature to ProteoExcel<small><sup>TP</sup></small> enhanced its applicability in mass spectrometry-based targeted proteomics. The developed LC-MS/MS-based quantitation method for determining clinically relevant efflux transporters will be useful in investigating the induction potential of other drugs.</p>","PeriodicalId":63,"journal":{"name":"Analyst","volume":" 5","pages":" 998-1011"},"PeriodicalIF":3.6000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analyst","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/an/d4an01514b","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Although combinational antiretroviral therapy has been proven highly effective, it suffers from drug–drug interactions, drug resistance and adverse reactions with long-term use. The introduction of novel drugs in antiretroviral therapy proposes newer treatment options. However, drug safety and their potential interactions after long-term therapy remain largely unexplored. In this study, the induction potential of bictegravir on efflux transporters at the protein level was assessed by quantifying the transporters using an LC-MS/MS-based method. A surrogate peptide approach was used for the simultaneous determination of P-gp, BCRP and MRP1 transporter proteins in rat peripheral blood mononuclear cells. The previously developed Excel-based ProteoExcelTP tool was utilized for selecting surrogate peptides corresponding to the target transporters. Moreover, ProteoExcelTP was integrated with a novel MRM prediction capability for predicting MRM transitions of selected surrogate peptides. The surrogate peptides LLSGQALK (415.2 → 716.4), SSLLDVLAAR (522.8 → 288.1) and EDLDLVLK (472.7 → 685.3) were selected for P-gp, BCRP and MRP1 transporter proteins, respectively. The peptides LLSGQALK, SSLLDVLAAR and EDLDLVLK were eluted at 5.4, 7.0 and 4.1 min, respectively. The findings of the study revealed that bictegravir could significantly induce BCRP transporter after one week of its administration to Sprague-Dawley rats. This finding can be utilized in the future to prevent transporter-mediated drug–drug interactions involving bictegravir. Moreover, the addition of MRM prediction feature to ProteoExcelTP enhanced its applicability in mass spectrometry-based targeted proteomics. The developed LC-MS/MS-based quantitation method for determining clinically relevant efflux transporters will be useful in investigating the induction potential of other drugs.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Analyst
Analyst 化学-分析化学
CiteScore
7.80
自引率
4.80%
发文量
636
审稿时长
1.9 months
期刊介绍: "Analyst" journal is the home of premier fundamental discoveries, inventions and applications in the analytical and bioanalytical sciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信